Abstract. Maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cleft palate formation in mice. This TCDD treatment, which may be considered an environmental factor in cleft palate formation, is associated with alterations in DNA methylation. However, the underlying molecular mechanisms of DNA methylation produced by TCDD in mouse embryos are poorly understood. DNA methyltransferases (DNMTs) and methyl-CpG binding domain proteins (MBDs) are thought to be closely associated with the actions of DNA methylation. Therefore, the present study tested the hypothesis that this cleft palate inducing effect of TCDD will alter the expression levels of DNMTs and various MBDs in palate tissue of fetal mice. Pregnant C57BL/6J mice were treated with either TCDD (64 µg/kg) or corn oil (control) at embryonic day 10.5 (E10.5) and fetal palates were harvested for structural and molecular analyses at E13.5, E14.5, E15.5 and E17.5. Expression levels of DNMTs and MBDs were assayed using reverse transcription-quantitative polymerase chain reaction and western blotting. The incidence of cleft palates in the TCDD group was 98.24%, whereas no cases of cleft palate were observed in the control group. Expression levels of DNMTs and MBDs were significantly increased in the TCDD group compared with the control. The results demonstrate clear alterations in DNMTs and MBDs, as induced by TCDD, and suggest that such alterations are important in cleft palate formation in fetal mice.
Introduction
Cleft lip with or without cleft palate (CL/P) is one of the most prevalent developmental deformities world-wide, with a prevalence ranging from approximately 1/300 to 1/2,500 of live births (1, 2) . CL/P results from a complex etiology due to multiple genetic and environmental risk factors (3) . Environmental factors, such as smoking, alcohol, caffeine, infections, corticosteroids, retinoic acid, dioxin, as well as other occupational pollutants, can seriously affect development of the fetus during pregnancy to eventually result in conditions such as CL/P (4).
In specific, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a highly toxic halogenated environmental contaminant that produces adverse biological effects, including developmental toxicity and teratogenesis (5) , has been shown to result in the formation of a cleft palate within mice (6) . Recent findings have established that epigenetic modifications are involved in murine palatogenesis induced by TCDD, with DNA methylation being considered as playing a key role in cleft palate formation (7) . The significance of DNA methylation has been revealed from findings demonstrating that global DNA methylation status was substantially enhanced in fetal mice following maternal exposure to TCDD, and this factor was thought to be a causative factor in palate malformation (8) . However, the underlying molecular mechanisms of DNA methylation caused by TCDD in mice require further elucidation.
DNA methylation is among the best studied epigenetic modifications and is closely related to disease and homeostatic imbalances in mammals, through its capacity of participating in proper embryonic development, gene expression regulation and even tumorigenesis (9, 10) . The dynamic patterns of DNA methylation are catalyzed by DNA methyltransferases (DNMTs) and then read and interpreted by specific proteins, called methyl-CpG binding domain proteins (MBDs) (11 It is well established that DNA methyltransferases are crucial for establishing DNA methylation patterns in mammals, and are thus responsible for maintenance of methylation (DNMT1) and de novo methylation (DNMT3a, 3b) (13, 14) . The methyl-CpG binding domain proteins, especially MeCP2, MBD2, MBD3, are critical players in determining the transcriptional state of epigenosomes, and therefore play an important role as facilitators of epigenetic-based repression (15) . Results from previous studies have demonstrated that cigarette smoke and alcohol cause changes in the expression of DNA methyltranferases and methyl-CpG binding domain proteins in murine embryonic cells (16, 17) . In this study, we utilized the mouse cleft palate model as accomplished by maternal exposure to TCDD, to elucidate the effects of epigenetic regulation, including DNMT1, DNMT3a, DNMT3b, MeCP2, MBD2 and MBD3 expression in vivo, and investigated their relationship and participation in TCDD-induced cleft palate.
Materials and methods
Animals. The present study was approved by the Transformation Center of Harbin Medical University (Harbin, China). C57BL/6J mice (8-10 weeks of age) consisting of 30 female experimental mice and 15 male mice used to impregnate the females were purchased from the Institute of Laboratory Animals of the Chinese Academy of Medical Sciences. The mice were housed under controlled laboratory conditions of 22-24˚C, 55±5% humidity, under a 12/12 h light/dark cycle, with standard laboratory chow and water ad libitum. After being acclimated to the laboratory conditions, two female mice were paired with one male overnight. Presence of vaginal plugs on the following morning was interpreted as a successful mating and was designated as embryonic day 0.5 (E0.5).
Drug administrations. At E10.5, pregnant mice were randomly divided into two groups: i) TCDD group-consisted of gavage with a single dose of 64 µg/kg TCDD; and ii) control group-mice that received an equal volume of corn oil. Following treatment, pregnant female mice were caged and fed separately. At E13.5, E14.5, E15.5 or E17.5, mice were euthanized using CO 2 . A total of three pregnant mice were euthanized at each time-point, and the total number of fetal mice present was recorded. Fetal palate tissue was quickly isolated from each embryo and stored at -80˚C.
Histological staining of sections. For histological analysis, the heads of the fetal mice were fixed in 4% paraformaldehyde (PFA), dehydrated in a graded series of ethanol, embedded in paraffin and then sectioned at 10 µm in the coronal plane. To assess the general morphology, deparaffinized sections were subjected to hematoxylin (Solarbio, Beijing, China) and eosin (Sinopharm Chemical Reagent Co., Ltd., Beijing, China) staining using established procedures.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was isolated from palatal shelves using a RNeasy Mini kit (BioTeke, Beijing, China) according to the manufacturer's instructions. The Super M-MLV RT kit (BioTeke) was used to synthesize first-standed cDNA. Each q-PCR reaction system was performed in a total volume of 20 µl: cDNA template 1 µl, forward and reverse primers (10 µm) each 0.5 µl, SYBR-Green Mastermix 10 µl and ddH 2 O 8 µl. The amplification protocol consisted of 40 cycles of denaturation for 10 sec at 95˚C, annealing for 20 sec at 60˚C, and elongation for 30 sec at 72˚C.
A SYBR-Green fluorescence quantification system (Bioneer, Daejeon, Korea) was utilized to perform the Real-time PCR analysis. β-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was used as an internal control and gene-specific mRNA expression was normalized to β-actin expression by using the 2 -∆∆Ct method. Primer sequences are shown in Table I .
Western blotting. Proteins extracts of the TCDD and control groups from E13.5 to E15.5 were performed using standard protocols and antibodies recognizing DNMT1, DNMT3a, DNMT3b, MeCP2, MBD2 and MBD3 (all from Bioss, Beijing, China). All data were normalized to the expression of β-actin (Santa Cruz Biotechnology, Inc.). The intensity of the bands was analyzed by densitometry.
Statistical analysis. Data from E13.5 to E15.5 in the two groups were presented as the mean ± SD and analyzed using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). Independent t-tests were used to establish statistically significant differences between two groups. A P<0.05 was required for results to be considered statistically significant. All experiments were performed at least in triplicate.
Results

TCDD treatments at E10.5 induced cleft palate in mice.
In fetuses excised from pregnant females who received TCDD at E10.5, the number of fetuses with CP only, without other obvious orofacial defects were: 14/14 at E13.5, 16/16 at E14.5, 13/14 at E15.5, and 13/13 at E17.5. In contrast, no cleft palates were observed in fetal mice within the control group. The morphological features of palatal development from E13.5 to E17.5 in fetuses from pregnant females treated with TCDD were examined under a stereomicroscope (Fig. 1) . H&E staining revealed that at E13.5, bilateral palate shelves of TCDD mice were observed to project downward on each side of the tongue and failed to elevate, which was similar to that observed in controls. At E14.5, palates of the controls were in the fusion stage, while TCDD-treated embryos showed bilateral palate shelves that were not fused. At E15.5 and E17.5, fetuses in the control group demonstrated a complete palate; while the absence of a successful adherence in palate shelves within the TCDD group resulted in a cleft palate.
TCDD activated the expression of DNMTs in palatal shelves.
To identify which DNA methyltransferase was regulated, we performed real-time quantitative PCR and western blot analysis for DNMT1, DNMT3a and DNMT3b. β-actin served as an internal reference and relative transcript and protein levels are shown in Fig. 2 . Our results revealed that mRNA levels of DNMT1, DNMT3a and DNMT3b were significantly increased in the TCDD, as compared with that of the control group at E13.5 to E15.5 (P<0.01). Within palatal shelves, a strong expression in DNMTs was obtained in the TCDD group from E13.5 to E15.5, while a relatively weak expression was present in the control group.
MeCP2, MBD2 and MBD3 are upregulated by TCDD in mice
palates. The mRNA expression of methyl-CpG binding domain proteins was detected using real-time quantitative PCR. The mRNA levels of MeCP2, MBD2 and MBD3 in the TCDD group at E13.5 to E15.5 were significantly increased (P<0.05), compared with those of controls (Fig. 3) . Protein expressions of MeCP2, MBD2 and MBD3 were identified using western blotting. Results from protein imprinting showed that protein expression levels of the TCDD group were significantly greater than in controls from E13.5 to E15.5 (P<0.05), which was in accordance with the trend observed for mRNA.
Temporal accumulations of DNMTs and MBDs in mouse embryonic palates.
The intensity of the bands resulting from western blot analysis was analyzed by densitometry. At E13.5, positive staining was sparsely present in palatal shelves. At E14.5, DNMTs and MBDs were strongly expressed in palatal shelves, with the strongest expression of DNMTs and MBDs being detected at E15.5 within the TCDD group.
Discussion
CL/P is a common birth defect notable for its significant morbidity and complex etiology. The complex etiology reflects the interaction of multiple genetic, epigenetic and environmental factors. One potential basis for this interaction involves that of environmental factors which can then affect gene expression via alterations in DNA methylation epigenetic modifications. DNA methylation is well known as an epigenetic marker involved in numerous biological processes which can induce gene expression changes without altering DNA sequences (18) . Although Kuriyama et al (19) have reported that DNA methylation may be crucial for murine palatogenesis, the precise molecular underpinnings directing epigenetic alterations that result in cleft palate remain obscure.
In eukaryotic cells, the establishment and maintenance of methylation patterns depends on the methylation modification system, which involves two important proteins, DNMTs and MBDs. Associated with this process are three enzymatically active DNA methaltransferases (DNMT1, DNMT3a, DNMT3b). DNMT1 is a maintenance methyltransferase that ensures inheritance of methylation patterns during cell division by preferentially methylating hemimethylated CG dimucleotides. DNMT3a and DNMT3b are responsible for de novo methylation, establishing DNA methylation patterns in germs cells. MeCP2, MBD2 and MBD3 are members of the MBD family of proteins that are associated with transcriptional activation or repression, regulation of chromatin structure, pluripotency, development and differentiation (20) . Mukhopadhyay et al (16) demonstrated that upon exposure to 80 µg/ml cigarette smoke extract for 24 h, first branchial arch-derived (1-BA) cells, which contribute to cleft palate formation, exhibited a decline in global DNA methylation and triggered a proteasomal-mediated degradation of DNMTs (DNMT1, DNMT3a), MeCP2 and MBD3. However, as this study was performed using an in vitro preparation, the question of whether such changes in gene expression of DNMTs and MBDs would be present in vivo has yet to be determined.
TCDD is a teratogenic reagent shown to be effective in inducing cleft palate in mice and therefore has been widely used as a model for the study of palate formation. Gestational exposure to TCDD can be considered as an environmental factor which influences the molecular development of palate tissue. Accordingly, we utilized this cleft palate model and directed our attention at examining potential in vivo changes that might be present in the expressions of DNMTs and MBDs in this model.
In this study, exposure of pregnant C57BL/6J mice to TCDD was effective in producing cleft palate in the fetuses. With use of a TCDD dose of 64 µg/kg as administered at E10.5, we obtained a 98.24% incidence of cleft palate. No other apparent external anomalies or complications were observed in the craniofacial tissue of these TCDD exposed litters. The morphological outcomes in terms of palatal development at E13.5, E14.5, E15.5 fetuses were evaluated with use of a stereomicroscope. H&E staining of embryo head sections at E14.5 and E15.5 showed a failure of palatal fusion in the TCDD group resulting in a cleft defect. By contrast, palatal shelve fusion was complete in the control group.
As it has been reported that abnormal methylation status may be a probable reason for cleft palate (12, 19, 21) , we next examined DNMT gene expression patterns in these mice. Our findings reveal that developmental exposure to TCDD significantly affects DNMT gene expression patterns. Results obtained from q-PCR analysis showed that Dnmt1, Dnmt3a and Dnmt3b were overexpressed at E13.5 in the TCDD group, and increased further at later stages of development. This trend was consistent with results obtained from western blotting. Overall, these changes are in accordance with recent studies by Wang et al (8) . One slight difference between our current results and that of Wang et al was the observation of a decline in the expression of Dnmt3b in their group, a difference which may be attributable to their use of a lower dose of 28 µg/kg TCDD as administered via oral gavage in the mice. However, the increased expression of DNMTs was clearly suggestive of stimulation by TCDD in maintenance (DNMT1) and de novo (DNMT3a and DNMT3b) DNMT activities. The fact that DNA methyltransferase activity is considered to be increased by folic acid (22) , and folic acid is regarded as the most effective treatment for fetal congenital malformations, including neural tube defects and CL/P (22, 23) , the significance of these increased expressions of DNMTs can be appreciated. Interestingly, the lack of folic acid intake in the peri-conceptional period has been identified as one of the high risk factors for CL/P (24) . Accordingly, we hypothesized that the aberrant increase of DNMTs may consume a large amount of folic acid and result in a folate deficiency within the body.
Coinciding with the changes in the expression of DNMT genes, we also observed a significant increase in MBDs during palatal development. Specifically, we observed that TCDD produced a significant over expression in both mRNA and proteins levels of the three methyl-CpG binding domain proteins, MeCP2, MBD2 and MBD3, in the palatal shelves of mice fetuses. These findings differ from those of Aluru et al (14) who reported a degradation in the expressions of MeCP2, MBD2 and MBD3 in zebrafish, the difference is likely due to the different species of mice and zebrafish. With regard to MBDs, Zhang et al (25) reported that MeCP2 was indispensable for normal neurological functioning and over expression of MeCP2 in mice resulted in neurobehavioural disorders, dendritic abnormalities and synaptic defects. Hendrich et al (26) showed that MBD2 and MBD3 played selective roles with regard to their function as transcriptional repressors. While Mbd3 -/-mice died during early embryogenesis, Mbd2 -/-mice were viable and fertile, suggesting that MBD2 and MBD3 exert distinct but interacting effects in mouse development. The results presented here are in accord with the changes in DNMTs expression levels observed, and it seems likely that the combined actions of DNMTs and MBDs may ultimately contribute to the aberrant methylation status of mice as induced by TCDD. The differential recruitment of DNA methyltransferases and methyl CpG-binding domain proteins are considered as factors which initiate the repression and silencing of Oct4 via hypomethylation of the Oct4 promoter (27) . As based upon a review of a large genome-wide association study of datasets, Oct4 was deemed to represent a loci harbor gene associated with CL/P (28).
In conclusion, the data presented here, which show increased recruitment of DNMTs and MBDs, and TCDD effects on DNMTs and MBDs expression as demonstrated in vivo in this mouse model of cleft palate, suggest that both the establishment and maintenance of methylation patterns may play an important role in murine palatogenesis.
